Heart Test Laboratories Statistics
Share Statistics
Heart Test Laboratories has 1.08M
shares outstanding. The number of shares has increased by 64.87%
in one year.
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | 64.87% |
| Shares Change (QoQ) | 10.26% |
| Owned by Institutions (%) | 2.89% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 246 |
| FTD / Avg. Volume | 1.67% |
Short Selling Information
The latest short interest is 9.04K, so 0.84% of the outstanding
shares have been sold short.
| Short Interest | 9.04K |
| Short % of Shares Out | 0.84% |
| Short % of Float | 0.84% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.49 and the forward
PE ratio is -0.53.
Heart Test Laboratories's PEG ratio is
0.
| PE Ratio | -0.49 |
| Forward PE | -0.53 |
| PS Ratio | 175.12 |
| Forward PS | 0.7 |
| PB Ratio | 0.45 |
| P/FCF Ratio | -0.53 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Heart Test Laboratories.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.2,
with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.2 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.17 |
| Interest Coverage | -17.81 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1,240 |
| Profits Per Employee | $-440,347.2 |
| Employee Count | 15 |
| Asset Turnover | 0 |
| Inventory Turnover | 0.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -30.74% in the
last 52 weeks. The beta is 2.63, so Heart Test Laboratories's
price volatility has been higher than the market average.
| Beta | 2.63 |
| 52-Week Price Change | -30.74% |
| 50-Day Moving Average | 3.24 |
| 200-Day Moving Average | 3.38 |
| Relative Strength Index (RSI) | 58.38 |
| Average Volume (20 Days) | 14,745 |
Income Statement
In the last 12 months, Heart Test Laboratories had revenue of 18.6K
and earned -6.61M
in profits. Earnings per share was -18.74.
| Revenue | 18.6K |
| Gross Profit | 12.52K |
| Operating Income | -6.31M |
| Net Income | -6.61M |
| EBITDA | -6.16M |
| EBIT | -6.25M |
| Earnings Per Share (EPS) | -18.74 |
Full Income StatementBalance Sheet
The company has 5.81M in cash and 1.04M in
debt, giving a net cash position of 4.77M.
| Cash & Cash Equivalents | 5.81M |
| Total Debt | 1.04M |
| Net Cash | 4.77M |
| Retained Earnings | -67.36M |
| Total Assets | 5.7M |
| Working Capital | -77.64K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -6.07M
and capital expenditures -125.27K, giving a free cash flow of -6.2M.
| Operating Cash Flow | -6.07M |
| Capital Expenditures | -125.27K |
| Free Cash Flow | -6.2M |
| FCF Per Share | -17.57 |
Full Cash Flow StatementMargins
Gross margin is 67.31%, with operating and profit margins of -33901.99% and -35511.87%.
| Gross Margin | 67.31% |
| Operating Margin | -33901.99% |
| Pretax Margin | -35511.87% |
| Profit Margin | -35511.87% |
| EBITDA Margin | -33096.75% |
| EBIT Margin | -33901.99% |
| FCF Margin | -33308.9% |
